Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-10-041895
Filing Date
2010-04-30
Accepted
2010-04-30 16:22:26
Documents
4
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K y84221e10vkza.htm 10-K/A 489212
2 EX-10.60 y84221exv10w60.htm EX-10.60 16473
3 EX-31.1 y84221exv31w1.htm EX-31.1 2206
4 EX-31.2 y84221exv31w2.htm EX-31.2 2582
  Complete submission text file 0000950123-10-041895.txt   511965
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-15190 | Film No.: 10787700
SIC: 2835 In Vitro & In Vivo Diagnostic Substances